Overview

  • Product nameAnti-TFIIB antibody [EPR4589]
    See all TFIIB primary antibodies
  • Description
    Rabbit monoclonal [EPR4589] to TFIIB
  • Tested applicationsSuitable for: WB, IPmore details
    Unsuitable for: Flow Cyt,ICC or IHC-P
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    A synthetic peptide corresponding to the C-terminus of Human TFIIB.

  • Positive control
    • HepG2, HeLa, Jurkat, K562, C6, RAW 264.7, and PC12 cell lysates.
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

Properties

Applications

Our Abpromise guarantee covers the use of ab109106 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 35 kDa.
IP 1/10 - 1/100.
  • Application notesIs unsuitable for Flow Cyt,ICC or IHC-P.
  • Target

    Anti-TFIIB antibody [EPR4589] images

    • All lanes : Anti-TFIIB antibody [EPR4589] (ab109106) at 1/1000 dilution

      Lane 1 : HepG2 cell lysate
      Lane 2 : HeLa cell lysate
      Lane 3 : Jurkat cell lysate
      Lane 4 : K562 cell lysate
      Lane 5 : C6 cell lysate
      Lane 6 : RAW 264.7 cell lysate
      Lane 7 : PC12 cell lysate

      Lysates/proteins at 10 µg per lane.


      Predicted band size : 35 kDa

    References for Anti-TFIIB antibody [EPR4589] (ab109106)

    ab109106 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab109106.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"